The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Guillain-Barré Syndrome-Global Market Insights and Sales Trends 2024
Synopsis
Guillain-Barré Syndrome is a rapid-onset muscle weakness caused by the immune system damaging the peripheral nervous system.
The global Guillain-Barré Syndrome market size is expected to reach US$ 546.2 million by 2029, growing at a CAGR of 2.8% from 2023 to 2029. The market is mainly driven by the significant applications of Guillain-Barré Syndrome in various end use industries. The expanding demands from the Hospital Pharmacies, Retail Pharmacies and Others,, are propelling Guillain-Barré Syndrome market. Intravenous Immunoglobulin, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Plasma Exchange segment is estimated at % CAGR for the next seven-year period.
Asia Pacific shows high growth potential for Guillain-Barré Syndrome market, driven by demand from China, the second largest economy with some signs of stabilising, the Guillain-Barré Syndrome market in China is forecast to reach US$ million by 2029, trailing a CAGR of % over the 2023-2029 period, while the U.S. market will reach US$ million by 2029, exhibiting a CAGR of % during the same period.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Guillain-Barré Syndrome, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Guillain-Barré Syndrome market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Guillain-Barré Syndrome market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Guillain-Barré Syndrome sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Guillain-Barré Syndrome covered in this report include Grifols, CSL Behring, Octapharma, Nihon Pharmaceutical, Akari Therapeutics, China Biologic Products Holdings, Biotest and Kedrion, etc.
The global Guillain-Barré Syndrome market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Grifols
CSL Behring
Octapharma
Nihon Pharmaceutical
Akari Therapeutics
China Biologic Products Holdings
Biotest
Kedrion
Global Guillain-Barré Syndrome market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Guillain-Barré Syndrome market, Segment by Type:
Intravenous Immunoglobulin
Plasma Exchange
Others
Global Guillain-Barré Syndrome market, by Application
Hospital Pharmacies
Retail Pharmacies
Others
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Guillain-Barré Syndrome companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Guillain-Barré Syndrome is a rapid-onset muscle weakness caused by the immune system damaging the peripheral nervous system.
The global Guillain-Barré Syndrome market size is expected to reach US$ 546.2 million by 2029, growing at a CAGR of 2.8% from 2023 to 2029. The market is mainly driven by the significant applications of Guillain-Barré Syndrome in various end use industries. The expanding demands from the Hospital Pharmacies, Retail Pharmacies and Others,, are propelling Guillain-Barré Syndrome market. Intravenous Immunoglobulin, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Plasma Exchange segment is estimated at % CAGR for the next seven-year period.
Asia Pacific shows high growth potential for Guillain-Barré Syndrome market, driven by demand from China, the second largest economy with some signs of stabilising, the Guillain-Barré Syndrome market in China is forecast to reach US$ million by 2029, trailing a CAGR of % over the 2023-2029 period, while the U.S. market will reach US$ million by 2029, exhibiting a CAGR of % during the same period.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Guillain-Barré Syndrome, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Guillain-Barré Syndrome market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Guillain-Barré Syndrome market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Guillain-Barré Syndrome sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Guillain-Barré Syndrome covered in this report include Grifols, CSL Behring, Octapharma, Nihon Pharmaceutical, Akari Therapeutics, China Biologic Products Holdings, Biotest and Kedrion, etc.
The global Guillain-Barré Syndrome market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Grifols
CSL Behring
Octapharma
Nihon Pharmaceutical
Akari Therapeutics
China Biologic Products Holdings
Biotest
Kedrion
Global Guillain-Barré Syndrome market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Guillain-Barré Syndrome market, Segment by Type:
Intravenous Immunoglobulin
Plasma Exchange
Others
Global Guillain-Barré Syndrome market, by Application
Hospital Pharmacies
Retail Pharmacies
Others
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Guillain-Barré Syndrome companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Index1 Market Overview of Guillain-Barré Syndrome
1.1 Guillain-Barré Syndrome Market Overview
1.1.1 Guillain-Barré Syndrome Product Scope
1.1.2 Guillain-Barré Syndrome Market Status and Outlook
1.2 Global Guillain-Barré Syndrome Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global Guillain-Barré Syndrome Market Size by Region (2018-2029)
1.4 Global Guillain-Barré Syndrome Historic Market Size by Region (2018-2023)
1.5 Global Guillain-Barré Syndrome Market Size Forecast by Region (2024-2029)
1.6 Key Regions, Guillain-Barré Syndrome Market Size (2018-2029)
1.6.1 North America Guillain-Barré Syndrome Market Size (2018-2029)
1.6.2 Europe Guillain-Barré Syndrome Market Size (2018-2029)
1.6.3 Asia-Pacific Guillain-Barré Syndrome Market Size (2018-2029)
1.6.4 Latin America Guillain-Barré Syndrome Market Size (2018-2029)
1.6.5 Middle East & Africa Guillain-Barré Syndrome Market Size (2018-2029)
2 Guillain-Barré Syndrome Market by Type
2.1 Introduction
2.1.1 Intravenous Immunoglobulin
2.1.2 Plasma Exchange
2.1.3 Others
2.2 Global Guillain-Barré Syndrome Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global Guillain-Barré Syndrome Historic Market Size by Type (2018-2023)
2.2.2 Global Guillain-Barré Syndrome Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America Guillain-Barré Syndrome Revenue Breakdown by Type (2018-2029)
2.3.2 Europe Guillain-Barré Syndrome Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific Guillain-Barré Syndrome Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America Guillain-Barré Syndrome Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa Guillain-Barré Syndrome Revenue Breakdown by Type (2018-2029)
3 Guillain-Barré Syndrome Market Overview by Application
3.1 Introduction
3.1.1 Hospital Pharmacies
3.1.2 Retail Pharmacies
3.1.3 Others
3.2 Global Guillain-Barré Syndrome Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global Guillain-Barré Syndrome Historic Market Size by Application (2018-2023)
3.2.2 Global Guillain-Barré Syndrome Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America Guillain-Barré Syndrome Revenue Breakdown by Application (2018-2029)
3.3.2 Europe Guillain-Barré Syndrome Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific Guillain-Barré Syndrome Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America Guillain-Barré Syndrome Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa Guillain-Barré Syndrome Revenue Breakdown by Application (2018-2029)
4 Guillain-Barré Syndrome Competition Analysis by Players
4.1 Global Guillain-Barré Syndrome Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Guillain-Barré Syndrome as of 2022)
4.3 Date of Key Players Enter into Guillain-Barré Syndrome Market
4.4 Global Top Players Guillain-Barré Syndrome Headquarters and Area Served
4.5 Key Players Guillain-Barré Syndrome Product Solution and Service
4.6 Competitive Status
4.6.1 Guillain-Barré Syndrome Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Grifols
5.1.1 Grifols Profile
5.1.2 Grifols Main Business
5.1.3 Grifols Guillain-Barré Syndrome Products, Services and Solutions
5.1.4 Grifols Guillain-Barré Syndrome Revenue (US$ Million) & (2018-2023)
5.1.5 Grifols Recent Developments
5.2 CSL Behring
5.2.1 CSL Behring Profile
5.2.2 CSL Behring Main Business
5.2.3 CSL Behring Guillain-Barré Syndrome Products, Services and Solutions
5.2.4 CSL Behring Guillain-Barré Syndrome Revenue (US$ Million) & (2018-2023)
5.2.5 CSL Behring Recent Developments
5.3 Octapharma
5.3.1 Octapharma Profile
5.3.2 Octapharma Main Business
5.3.3 Octapharma Guillain-Barré Syndrome Products, Services and Solutions
5.3.4 Octapharma Guillain-Barré Syndrome Revenue (US$ Million) & (2018-2023)
5.3.5 Nihon Pharmaceutical Recent Developments
5.4 Nihon Pharmaceutical
5.4.1 Nihon Pharmaceutical Profile
5.4.2 Nihon Pharmaceutical Main Business
5.4.3 Nihon Pharmaceutical Guillain-Barré Syndrome Products, Services and Solutions
5.4.4 Nihon Pharmaceutical Guillain-Barré Syndrome Revenue (US$ Million) & (2018-2023)
5.4.5 Nihon Pharmaceutical Recent Developments
5.5 Akari Therapeutics
5.5.1 Akari Therapeutics Profile
5.5.2 Akari Therapeutics Main Business
5.5.3 Akari Therapeutics Guillain-Barré Syndrome Products, Services and Solutions
5.5.4 Akari Therapeutics Guillain-Barré Syndrome Revenue (US$ Million) & (2018-2023)
5.5.5 Akari Therapeutics Recent Developments
5.6 China Biologic Products Holdings
5.6.1 China Biologic Products Holdings Profile
5.6.2 China Biologic Products Holdings Main Business
5.6.3 China Biologic Products Holdings Guillain-Barré Syndrome Products, Services and Solutions
5.6.4 China Biologic Products Holdings Guillain-Barré Syndrome Revenue (US$ Million) & (2018-2023)
5.6.5 China Biologic Products Holdings Recent Developments
5.7 Biotest
5.7.1 Biotest Profile
5.7.2 Biotest Main Business
5.7.3 Biotest Guillain-Barré Syndrome Products, Services and Solutions
5.7.4 Biotest Guillain-Barré Syndrome Revenue (US$ Million) & (2018-2023)
5.7.5 Biotest Recent Developments
5.8 Kedrion
5.8.1 Kedrion Profile
5.8.2 Kedrion Main Business
5.8.3 Kedrion Guillain-Barré Syndrome Products, Services and Solutions
5.8.4 Kedrion Guillain-Barré Syndrome Revenue (US$ Million) & (2018-2023)
5.8.5 Kedrion Recent Developments
6 North America
6.1 North America Guillain-Barré Syndrome Market Size by Country (2018-2029)
6.2 U.S.
6.3 Canada
7 Europe
7.1 Europe Guillain-Barré Syndrome Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Guillain-Barré Syndrome Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Guillain-Barré Syndrome Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Guillain-Barré Syndrome Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Guillain-Barré Syndrome Market Dynamics
11.1 Guillain-Barré Syndrome Industry Trends
11.2 Guillain-Barré Syndrome Market Drivers
11.3 Guillain-Barré Syndrome Market Challenges
11.4 Guillain-Barré Syndrome Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
